Total Funding
32
67
Total FundingSeries A raised
Growth Score
-29 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
34066
Pear Bio is an AI-enabled biotech company focused on patient-centered cancer precision medicine
Past Role: Ourotech, Founder & CEO
About the Company
Pear Bio is a Boston and London-based AI-enabled biotech company. We develop functional precision medicine-guided therapeutics for patients with hard-to-treat cancers. We take tumor biopsies and blood from cancer patients to find new targets with multi-omics. We then test the efficacy of generated drug candidates directly on patient tumor samples
using a proprietary immune-microtumor system. We have best-in-class and first-in-class internal drug discovery programs, and we are using our 3D immune-microtumor platform to position our drug candidates in the right indications/populations and in smarter combination therapies.
